secErbB4-26/549 antagonizes ligand-induced ErbB4 tyrosine phosphorylation

被引:13
作者
Gilmore, JL [1 ]
Riese, DJ [1 ]
机构
[1] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA
关键词
ErbB4; ErbB3; neuregulin; antagonist;
D O I
10.3727/0965040042707907
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ErbB4 is a member of the ErbB family of receptor tyrosine kinases. Because of a paucity of appropriate pharmacologic tools, little is known about ErbB4 functions in vivo. In response to this need, we hypothesized that a recombinant form of the extracellular domain of ErbB4 would antagonize ligand-induced receptor tyrosine phosphorylation and subsequent downstream signaling and could be used to probe ErbB4 function. Indeed, we show here that one such ErbB4 protein, secErbB4-26/549, is a potent inhibitor of ligand-induced ErbB4 tyrosine phosphorylation and of ligand-induced ErbB4 coupling to biological responses. Furthermore, we demonstrate that secErbB4-26/549 antagonizes ligand-induced ErbB4 signaling by acting as a ligand sink. Thus, secErbB4-26/549 is suitable for elucidating the effects of ErbB4 ligand-induced ErbB signaling in a variety of biological contexts.
引用
收藏
页码:589 / 602
页数:14
相关论文
共 77 条
[1]   Gene expression profiling of ErbB receptor and ligand-dependent transcription [J].
Amin, DN ;
Perkins, AS ;
Stern, DF .
ONCOGENE, 2004, 23 (07) :1428-1438
[2]   Expression of herstatin, an autoinhibitor of HER-2/neu, inhibits transactivation of HER-3 by HER-2 and blocks EGF activation of the EGF receptor [J].
Azios, NG ;
Romero, FJ ;
Denton, MC ;
Doherty, JK ;
Clinton, GM .
ONCOGENE, 2001, 20 (37) :5199-5209
[3]  
Bacus SS, 1996, AM J PATHOL, V148, P549
[4]   ON THE TERTIARY STRUCTURE OF THE EXTRACELLULAR DOMAINS OF THE EPIDERMAL GROWTH-FACTOR AND INSULIN-RECEPTORS [J].
BAJAJ, M ;
WATERFIELD, MD ;
SCHLESSINGER, J ;
TAYLOR, WR ;
BLUNDELL, T .
BIOCHIMICA ET BIOPHYSICA ACTA, 1987, 916 (02) :220-226
[5]   INHIBITION OF TYROSINE KINASE-ACTIVITY OF THE EPIDERMAL GROWTH-FACTOR (EGF) RECEPTOR BY A TRUNCATED RECEPTOR FORM THAT BINDS TO EGF - ROLE FOR INTERRECEPTOR INTERACTION IN KINASE REGULATION [J].
BASU, A ;
RAGHUNATH, M ;
BISHAYEE, S ;
DAS, M .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (02) :671-677
[6]   An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors [J].
Burgess, AW ;
Cho, HS ;
Eigenbrot, C ;
Ferguson, KM ;
Garrett, TPJ ;
Leahy, DJ ;
Lemmon, MA ;
Sliwkowski, MX ;
Ward, CW ;
Yokoyama, S .
MOLECULAR CELL, 2003, 12 (03) :541-552
[7]   IN HIV-INFECTED INDIVIDUALS WHO DESIRE COMBINATION ANTIVIRAL THERAPY, ZIDOVUDINE PLUS ZALCITABINE IS PREFERRED TO ZIDOVUDINE PLUS DIDANOSINE [J].
CARR, A ;
COOPER, DA .
REVIEWS IN MEDICAL VIROLOGY, 1994, 4 (01) :5-8
[8]   Ligands for ErbB-family receptors encoded by a neuregulin-like gene [J].
Chang, H ;
Riese, DJ ;
Gilbert, W ;
Stern, DF ;
McMahan, UJ .
NATURE, 1997, 387 (6632) :509-512
[9]   Structure of the extracellular region of HER3 reveals an interdomain tether [J].
Cho, HS ;
Leahy, DJ .
SCIENCE, 2002, 297 (5585) :1330-1333
[10]   Identification of a determinant of epidermal growth factor receptor ligand-binding specificity using a truncated, high-affinity form of the ectodomain [J].
Elleman, TC ;
Domagala, T ;
McKern, NM ;
Nerrie, M ;
Lönnqvist, B ;
Adams, TE ;
Lewis, J ;
Lovrecz, GO ;
Hoyne, PA ;
Richards, KM ;
Howlett, GJ ;
Rothacker, J ;
Jorissen, RN ;
Lou, MZ ;
Garrett, TPJ ;
Burgess, AW ;
Nice, EC ;
Ward, CW .
BIOCHEMISTRY, 2001, 40 (30) :8930-8939